Colgate-Palmolive Company $CL Shares Sold by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp lowered its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 96.6% during the first quarter, Holdings Channel reports. The fund owned 57,798 shares of the company’s stock after selling 1,625,442 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Colgate-Palmolive were worth $4,926,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Colgate-Palmolive by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after purchasing an additional 1,026,985 shares during the period. Geode Capital Management LLC increased its holdings in Colgate-Palmolive by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock worth $1,754,657,000 after purchasing an additional 304,426 shares during the period. Morgan Stanley raised its position in Colgate-Palmolive by 1.7% in the 4th quarter. Morgan Stanley now owns 19,246,217 shares of the company’s stock valued at $1,520,836,000 after purchasing an additional 323,367 shares in the last quarter. Bank of New York Mellon Corp raised its position in Colgate-Palmolive by 172.5% in the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock valued at $1,067,211,000 after purchasing an additional 7,927,238 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $861,670,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.0%

Shares of NYSE:CL opened at $90.74 on Monday. The firm has a 50 day simple moving average of $90.77 and a 200-day simple moving average of $89.05. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The company has a market capitalization of $72.61 billion, a PE ratio of 35.31, a P/E/G ratio of 4.78 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period last year, the firm posted $0.91 EPS. The company’s revenue was up 8.4% on a year-over-year basis. On average, equities analysts predict that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CL shares. Royal Bank Of Canada reissued an “outperform” rating and set a $102.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Sunday, March 29th. Barclays lifted their price target on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Sanford C. Bernstein initiated coverage on shares of Colgate-Palmolive in a research report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price objective on the stock. Finally, Weiss Ratings upgraded shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.82.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.